Beijing Biostar Pharmaceuticals Co., Ltd. (SEHK: 2563)
Health Care · Biotechnology · CN
HK$3.38
-4.66% today · -61.2% 1Y
Beijing Biostar Pharmaceuticals Co., Ltd. (SEHK: 2563) operates in the Biotechnology industry within the Health Care sector. The company is valued at $156.80M and employs 134 people.
Over the last twelve months the share price has lost 61.2%, trading between 2.40 and 9.63.
Tweenvest scores Beijing Biostar Pharmaceuticals Co., Ltd. across four factors: quality 32/100, value 32/100. Its strongest factor is quality.
2563 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $156.80M
- Revenue (TTM)
- $4.77M
- P/E
- —
- EPS
- -0.36
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$9.63
- 52-week low
- HK$2.40
- Avg volume (3M)
- —
- Shares outstanding
- 364.59M
- Employees
- 134
- Next earnings
- —
About Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
- ISIN
- CNE100006NB3
- Founded
- 2002
- Listed since
- Oct 31, 2024
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.